TH and depressive symptom measurement: We assessed the loss of TH+ cells and TH fibers associated with different doses of 6-OHDA, and examined dose-dependent motor symptoms (including gait changes), non-motor symptoms (anxiety-like behaviors, depression-like behaviors), mitochondrial dysfunction and glial cell activation.